Search for Clinical Trial Results

Mastocytosis, Systemic - 25 Studies Found
Status | Study |
Completed |
Study Name: Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis Condition: Systemic Mastocytosis Date: 2007-03-19 Interventions: Drug: RAD001 (Everolimus) Oral RAD001 10 mg daily for 30 days |
Completed |
Study Name: Use of Tamoxifen in Systemic Mastocytosis Condition: Systemic Mastocytosis Date: 2007-12-25 |
Completed |
Study Name: Imatinib in KIT-negative Systemic Mastocytosis Condition: Systemic Mastocytosis Date: 2011-02-16 Interventions: Drug: Imatinib Mesylate
|
Recruiting |
Study Name: Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis Condition: Systemic Mastocytosis Date: 2015-05-05 Interventions: Procedure: Mastocytosis diagnosis Some samples will be extracted from bone marrow aspirate and periphera |
Recruiting |
Study Name: Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis Condition: Systemic Mastocytosis Date: 2012-05-16 Interventions: Drug: Cladribine and pegylated interpheron alpha-2a Cladri |
Recruiting |
Study Name: Midostaurin in Indolent Systemic Mastocytosis Condition: Indolent Systemic Mastocytosis Date: 2013-08-07 Interventions: Drug: Midostaurin, Midostaurin, twice daily 100 mg orally, continuously for 6 months |
Terminated |
Study Name: Obatoclax for Systemic Mastocytosis Condition:
Date: 2009-06-09 Interventions: Drug: Obatoclax Mesylate 30 mg given by vein over 3 hours on Days 1-3 of each 14-day study cycle. |
Completed |
Study Name: Treatment of Indolent Systemic Mastocytosis With PA101 Condition:
|
Completed |
Study Name: Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) Condition:
Date: 2007-06-26 Interventions: Drug: Ontak (Denileukin Diftitox) 9 µg/kg by vein Days 1-5 of a 21 day cycle. |
Recruiting |
Study Name: Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis Condition:
Interventions: |